Authors:
HAMMERLE T
HIMMELSPACH M
DORNER F
FALKNER FG
Citation: T. Hammerle et al., A SENSITIVE PCR ASSAY SYSTEM FOR THE QUANTITATION OF VIRAL GENOME EQUIVALENTS - HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) AND HEPATITIS-BVIRUS (HBV), Archives of virology, 142(7), 1997, pp. 1297-1306
Authors:
SCHLOKAT U
FISCHER BE
HERLITSCHKA S
ANTOINE G
PREININGER A
MOHR G
HIMMELSPACH M
KISTNER O
FALKNER FG
DORNER F
Citation: U. Schlokat et al., PRODUCTION OF HIGHLY HOMOGENEOUS AND STRUCTURALLY INTACT RECOMBINANT VON-WILLEBRAND-FACTOR MULTIMERS BY FURIN-MEDIATED PROPEPTIDE REMOVAL IN-VITRO, Biotechnology and applied biochemistry, 24, 1996, pp. 257-267
Authors:
BEVEC D
JAKSCHE H
OFT M
WOHL T
HIMMELSPACH M
PACHER A
SCHEBESTA M
KOETTNITZ K
DOBROVNIK M
CSONGA R
LOTTSPEICH F
HAUBER J
Citation: D. Bevec et al., INHIBITION OF HIV-1 REPLICATION IN LYMPHOCYTES BY MUTANTS OF THE REV COFACTOR EIF-5A, Science, 271(5257), 1996, pp. 1858-1860
Authors:
HIMMELSPACH M
GRUBER F
ANTOINE G
FALKNER FG
DORNER F
HAMMERLE T
Citation: M. Himmelspach et al., SPECIFIC QUANTITATION OF GENOMIC DNA IN THE FEMTOGRAM RANGE BY AMPLIFICATION OF REPETITIVE SEQUENCES, Analytical biochemistry, 242(2), 1996, pp. 240-247
Authors:
HIMMELSPACH M
CAVALOC Y
CHEBLI K
STEVENIN J
GATTONI R
Citation: M. Himmelspach et al., TITRATION OF SERINE ARGININE (SR) SPLICING FACTORS DURING ADENOVIRAL INFECTION MODULATES E1A PRE-MESSENGER-RNA ALTERNATIVE SPLICING/, RNA, 1(8), 1995, pp. 794-806
Authors:
HAMMERLE T
HIMMELSPACH M
FALKNER FG
ZERLAUTH G
IGEL H
BARRETT N
DORNER F
Citation: T. Hammerle et al., NEW ADDITIONAL RELEASE CRITERIA FOR BLOOD PRODUCTS DERIVED FROM POOLED HUMAN PLASMA, Thrombosis and haemostasis, 73(6), 1995, pp. 1023-1023
Authors:
RUHL M
HIMMELSPACH M
BAHR GM
HAMMERSCHMID F
JAKSCHE H
WOLFF B
ASCHAUER H
FARRINGTON GK
PROBST H
BEVEC D
HAUBER J
Citation: M. Ruhl et al., EUKARYOTIC INITIATION FACTOR-5A IS A CELLULAR TARGET OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REV ACTIVATION DOMAIN MEDIATING TRANSACTIVATION, The Journal of cell biology, 123(6), 1993, pp. 1309-1320